|
|
||||||||
1 Hill Farm Research Station, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, 11959 Hwy 9, Homer 71040
2 Merial Limited, 115 Transtech Dr., Athens, GA 30601
The efficacy of two commercially available Escherichia coli J5 bacterins was investigated. Jersey cows were randomly assigned to one of three treatment groups: 1) unvaccinated controls, 2) vaccinated with J-VAC (Merial Limited, Athens, GA), and 3) vaccinated with J5 bacterin. All cows were vaccinated at drying off and at 2 wk before anticipated calving. Cows that were vaccinated with the J5 bacterin also received a third immunization at calving. One quarter of each cow was challenged with approximately 64 cfu of E. coli at 14 to 30 d postcalving. Immunization by either vaccine did not influence the severity of coliform mastitis; however, the mean number of colony-forming units of E. coli recovered from challenged quarters was significantly lower for immunized cows than for control cows at 144 h postchallenge. Serum and mammary secretion immunoglobulin (Ig)G, IgG1, and IgG2 titers against E. coli J5 whole-cell antigens were enhanced in vaccinated cows. Serum and mammary secretion IgM were not different among treatment groups. Somatic cell counts in milk from challenged quarters, rectal temperatures, and the clinical status of cows following intramammary challenge were not different among treatment groups.
Key Words: Escherichia coli J5 immunization intramammary challenge mastitis
Submitted on September 21, 1999
Accepted on April 12, 2000
This article has been cited by other articles:
![]() |
D. J. Wilson, B. A. Mallard, J. L. Burton, Y. H. Schukken, and Y. T. Grohn Association of Escherichia coli J5-Specific Serum Antibody Responses with Clinical Mastitis Outcome for J5 Vaccinate and Control Dairy Cattle Clin. Vaccine Immunol., February 1, 2009; 16(2): 209 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Bannerman, A. C. W. Kauf, M. J. Paape, H. R. Springer, and J. P. Goff Comparison of Holstein and Jersey Innate Immune Responses to Escherichia coli Intramammary Infection J Dairy Sci, June 1, 2008; 91(6): 2225 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Wilson, B. A. Mallard, J. L. Burton, Y. H. Schukken, and Y. T. Grohn Milk and Serum J5-Specific Antibody Responses, Milk Production Change, and Clinical Effects following Intramammary Escherichia coli Challenge for J5 Vaccinate and Control Cows Clin. Vaccine Immunol., June 1, 2007; 14(6): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hogan, V. B. Cannon, K. L. Smith, C. Rinehart, and S. Miller Effects of Adjuvants on Safety and Efficacy of an Escherichia coli J5 Bacterin J Dairy Sci, February 1, 2005; 88(2): 534 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chaiyotwittayakun, J. L. Burton, P. S. D. Weber, K. Kizilkaya, F. F. Cardoso, and R. J. Erskine Hyperimmunization of Steers with J5 Escherichia coli Bacterin: Effects on Isotype-Specific Serum Antibody Responses and Cross Reactivity with Heterogeneous Gram-Negative Bacteria J Dairy Sci, October 1, 2004; 87(10): 3375 - 3385. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |